# EGPA presenting as sudden cardiac arrest: a case report and review of cardiac manifestations

**Authors:** Huihui Zhang, Miaolin Zhang, Tao Yu, Zhi Zhang, Mengyang Cai, Gang Wang, Weizong Zhang, Huamin Yu, Hong Yuan

PMC · DOI: 10.3389/fimmu.2025.1749843 · 2026-01-15

## TL;DR

A rare case of EGPA causing sudden cardiac arrest is reported, highlighting the importance of early diagnosis and treatment.

## Contribution

This is the first documented case of EGPA initially presenting as Adams-Stokes syndrome.

## Key findings

- A 27-year-old female with EGPA presented with Adams-Stokes syndrome and significant eosinophilia.
- Emergency treatment with methylprednisolone and mepolizumab restored sinus rhythm and improved cardiac function.
- The case emphasizes the need to consider EGPA in unexplained high-grade heart block.

## Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis in which cardiac involvement is a primary cause of mortality. Complete heart block presenting as Adams-Stokes syndrome is a rare but critical complication. Notably, to our knowledge, EGPA initially manifesting as Adams-Stokes syndrome has not been previously documented, based on a comprehensive review of the literature. We report a 27-year-old female presenting with recurrent syncope and seizures. Laboratory tests revealed significant eosinophilia (49.5%), and cardiac workup confirmed third-degree atrioventricular block. A diagnosis of EGPA was established based on the 2022 ACR/EULAR criteria (score=13). Emergency treatment involved temporary pacing and methylprednisolone pulse therapy, followed by mepolizumab induction. Sinus rhythm recovered within 24 hours. During a two-month follow-up, the patient maintained remission with normalized eosinophil counts and improved cardiac function. This case highlights the importance of including EGPA in the differential diagnosis of unexplained high-grade heart block and supports the efficacy of early immunosuppressive therapy in reversing life-threatening cardiac complications.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741)
- **Diseases:** Eosinophilic granulomatosis with polyangiitis (MONDO:0015943), Adams-Stokes syndrome (MONDO:0043475)

## Full-text entities

- **Diseases:** systemic vasculitis (MESH:D056647), heart block (MESH:D006327), cardiac complications (MESH:D006331), syncope (MESH:D013575), EGPA (MESH:D014890), seizures (MESH:D012640), atrioventricular block (MESH:D054537), Adams-Stokes syndrome (MESH:D000219), eosinophilia (MESH:D004802), cardiac arrest (MESH:D006323)
- **Chemicals:** mepolizumab (MESH:C434107), methylprednisolone (MESH:D008775)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12852314/full.md

---
Source: https://tomesphere.com/paper/PMC12852314